Current Opinion in Infectious Diseases

Article	Citations
Strongyloidiasis-related lung involvement: too much of a bad thing	52
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era	49
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel	48
Editorial introductions	44
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV	43
La Crosse virus encephalitis in children	42
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians	41
From diagnosis to management: current perspectives on congenital cytomegalovirus infection	35
Complexities of cardiomyopathy in septic shock	33
Skin and soft tissue infections in the elderly	32
Corticosteroids for viral central nervous system infections	30
Surgical management of cystic echinococcosis of the liver	29
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside	29
Typhoid fever control in the 21st century: where are we now?	28
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response	28
Fusarium species central nervous system infection	28
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?	27
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients	26
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management	26
Managing cognitive impairment in people with HIV: Erratum	26
Viral meningitis and encephalitis: an update	25
Mycobacterial skin infection	25
Mpox in people living with HIV	24
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?	24
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies	22

Resistant herpes simplex virus infections – who, when, and what's new?	22
Tuberculosis molecular bacterial load assay in the management of tuberculosis	22
Tick-borne encephalitis	21
Malaria in pregnancy: baby steps	21
Using antibiotics wisely	20
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach	20
Editorial introductions	20
Does climate change threaten delivery of HIV care in resource-limited settings?	20
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention	20
Interventions for polyoma virus-associated hemorrhagic cystitis	18
Diagnostic approach and update on encephalitis	18
Gut microbiome and its clinical implications: exploring the key players in human health	17
CMV antiviral stewardship in transplantation – the next frontier	17
Diagnostic stewardship: what impacts antibiotics use?	17
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis	17
Haemophilus ducreyi in genital ulcer disease: new developments in an old disease	16
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19	16
Appropriate surgical management in skin and soft tissue infections	16
The plumbing problem: rising antimicrobial resistance in building water systems	15
Update on the treatment of chronic pulmonary aspergillosis	15
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV	15
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change	14
Risk stratification for selecting empiric antibiotherapy during and after COVID-19	14
The microbiota in respiratory tract infections: from association to intervention	14
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles	14
Editorial introductions	14
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections	14
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae	13
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management	13
The secret weapon to reduce multidrug-resistant Gram-negative infections: can vaccines help decrease MDR risk?	13
Editorial: Pathogenesis and immune response – editorial	13
Childhood tuberculosis	13
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential	13
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities	13
Update on drug treatments for multidrug resistant tuberculosis	12
Travellers’ diarrhoea – solidifying our knowledgebase	12
An overview of risk factors, management and prevention of cochlear implant infections	12
Interpreting and managing preservation fluids positive for Gram-negative bacteria	12
Respiratory metagenomics: route to routine service	12
Combatting antimicrobial-resistant Neisseria gonorrhoeae: new antibiotics and the pipeline of antigonococcal therapeutics	12
Data science for pediatric infectious disease: utilizing COVID-19 as a model	12
The microbiome as a biomarker of anal precancerous lesions in people with HIV	12
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients	12
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives	11
Short-course antibiotic strategies for ventilator-associated pneumonia	11
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans	11
Short treatment duration for community-acquired pneumonia	11
Urinary tract infections in immunocompromised patients	11
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis	11
The disease burden of respiratory syncytial virus in Infants	11

Skin and soft tissue infections in solid organ transplants	10
Novel techniques in the treatment of skin and soft tissue infection	10
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities	10
Burden of influenza in the elderly: a narrative review	10
Neurobrucellosis	10
Identifying patients with difficult-to-treat acute bacterial skin infections	10
The evolution of knowledge for treating Gram-negative bacterial infections	9
Genome-wide approaches to bacterial strain typing: a history and review of recent methodological advances	9
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients	9
Therapeutic agents for the treatment of human mpox	9
Chagas disease in the immunocompromised host	9
Updates on the neurological manifestations of SARS-CoV-2 infection	9
Antibiotic treatment of acute bacterial skin and skin structure infections	9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity	9
Immune responses and severe dengue: what have we learned?	9
A new era of HIV care for age-associated multimorbidity	9
How I manage patients with New Delhi metallo-beta-lactamase and OXA-48-producing Enterobacterales infections: a practical approach	8
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens	8
Surgical site infection prophylaxis: what have we learned and are we making progress?	8
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention	8
Endemic viral infections in immunocompromised hosts: Dengue, Chikungunya, Zika	8
Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach	8
The role of older antibiotics in the treatment of skin and soft tissue infections: current perspectives	8
Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice	8
Tropical gastrointestinal infections of contemporary public health importance	8
Management of nonfermenting gram-negative infections: a critique of the guidelines	7
When is it a sexually transmitted infection? Intimate contact transmission of pathogens not traditionally defined as STIs	7
Preventing respiratory viral transmission in healthcare settings	7
Editorial introductions	7
Universal versus targeted treatment of neonatal herpes simplex virus among neonates presenting for sepsis evaluations	7
Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections	7
The implications of the COVID-19 pandemic for long term care facilities	7
Editorial introductions	7
Pneumocystis jiroveci: still troublesome to diagnose and treat	7
Medical management of cystic echinococcosis	7
Long COVID in children and young people: then and now	7
Editorial: Friends and foes: “The quarrels of friends are the opportunities of foes”	6
Recent advances in the management of skin and soft tissue infections	6
Choosing antibiotic therapy for severe community-acquired pneumonia	6
Editorial introductions	6
Community-acquired skin and soft-tissue infections in people who inject drugs	6
Current status of primary, secondary and tertiary prevention of congenital cytomegalovirus disease: a call to action	6
Editorial introductions	6
Antiviral therapies for influenza	6
Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?	6
The power of story: what Victorian novels can teach us about public health	5
Editorial introductions	5
Risk factors for severity in seasonal respiratory viral infections and how they guide management in hematopoietic cell transplant recipients	5
Horizontal versus vertical strategies for infection prevention: current practices and controversies	5
Viral diarrheas – newer advances in diagnosis and management	5
Risk factors for cognitive decline in persons with HIV	5
Climate change and resilience for antimicrobial stewardship and infection prevention	5
Human toxoplasmosis: current advances in the field	5
Is it possible to identify genotypes underlying resistant phenotypes in Gram-negative pathogens?	5
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings	5
Dengue encephalitis: what's new?	5
From clinical trials to daily practice: how to adequately administer sulbactam-durlobactam? alone or combined with imipenem?	5
Current international and national guidelines for managing skin and soft tissue infections	5
Giardia and growth impairment in children in high-prevalence settings: consequence or co-incidence?	5
Viral infections and inborn errors of immunity	5
Editorial introductions	5
Brain abscess in immunocompetent patients: recent findings	5
A work in progress: antimicrobial stewardship in solid organ transplant patient populations	4
Nontyphoidal Salmonella infections acquired from poultry	4
Editorial introductions	4
The microbiology and pathogenesis of nonfermenting Gram-negative infections	4
Skin and soft tissue infections due to rapidly growing mycobacteria	4
Cutaneous manifestations associated with HIV preexposure prophylaxis: what to expect and when to worry	4
Escherichia coli 0157:H7 virulence factors and the ruminant reservoir	4
NSAIDs for early management of acute respiratory infections	4
Gastrointestinal involvement in post-acute Coronavirus disease (COVID)-19 syndrome	4
Mpox exposure and transmission in healthcare settings during the 2022 global outbreak	4
Respiratory viral infections in children with cancer and febrile neutropenia and children undergoing hematopoietic stem cell transplantation	4
To proceed or delay? The dilemma of community-acquired respiratory viruses in adults and pediatrics before allogeneic stem cell transplantation and chimeric-antigen-receptor T-cell therapy	4
Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children	4
Lenacapavir: a first-in-class capsid inhibitor for HIV treatment and prevention	4
Neutropenia and antibiotics: when, what, how and why?	4
Vaccine hesitancy and other challenges to sexually transmitted infection vaccine acceptance	4
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients	4
Advances and challenges in sexually transmitted infections prevention among men who have sex with men in Asia	4

Editorial introductions	4
HIV and menopause: current evidence, gaps, and future directions for integrated care	4
Infectious mononucleosis: new concepts in clinical presentation, epidemiology, and host response	4
Clinical trials that could change the management of severe multidrug-resistant Gram-negative infections	4
The present and future of blood virome in allogeneic hematopoietic cell transplant recipients	4
The role of sulbactam-durlobactam in treating carbapenem-resistant Acinetobacter infections	4
Central nervous system infections in the tropics	4
Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipients	4
Strongyloides stercoralis infection in solid organ transplant recipients	4
Current challenges in neurocysticercosis: recent data and where we are heading	4
‘No cyst, no echinococcosis’: a scoping review update on the diagnosis of cystic echinococcosis after the issue of the WHO-IWGE Expert Consensus and current perspectives	4
Mpox: emergence following smallpox eradication, ongoing outbreaks and strategies for prevention	4
New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteria	4
The role of the genital microbiota in the acquisition and pathogenesis of sexually transmitted infections	4
Infant feeding: emerging concepts to prevent HIV transmission	4
Pathogenesis and immune response: editorial Biomedical research discoveries: acceptance, controversies and current challenges to improving human health	3
Host-directed immunotherapy for viral infections	3
Melioidosis and Burkholderia pseudomallei: progress in epidemiology, diagnosis, treatment and vaccination	3
Current challenges in acute bacterial skin infection management	3
How to treat severe Acinetobacter baumannii infections	3
Prevention and treatment of recurrent cellulitis	3
Left ventricular assist device-associated driveline infections as a specific form of complicated skin and soft tissue infection/acute bacterial skin and skin structure infection – issues and therapeut	3
New drugs for the management of tuberculosis	3
When antimicrobial stewardship begins with microbiological test requests: the case of asymptomatic bacteriuria	3
Editorial introductions	3
Current treatment options for pneumonia caused by carbapenem-resistant Acinetobacter baumannii	3
Hot topics in pediatric infectious diseases: vaccines, molecular diagnosis, and emerging challenges post COVID-19	3
Hyperammonemia syndrome in immunosuppressed individuals	3
The disease burden of respiratory syncytial virus in older adults	3
Endemic mycoses – are we making progress in management?	3
Editorial introductions	3
What is the clinical significance of ‘heteroresistance’ in nonfermenting Gram-negative strains?	3
Not all carbapenem-resistant Pseudomonas aeruginosa strains are alike: tailoring antibiotic therapy based on resistance mechanisms	3
Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus	3
Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic?	3
Editorial introductions	3
Dermatological manifestations during Dengue, Chikungunya, and Zika infections	3